Biogen forecasts 2015 earnings well ahead of Street view
January 29, 2015 at 16:33 PM EST
Jan 29 (Reuters) - Biogen Idec Inc on Thursday reported higher-than-expected fourth-quarter profit on strong demand for its oral multiple sclerosis drug Tecfidera and issued a forecast for 2015 earnings far higher than Wall Street forecasts.